University of Thessaly (UTH)
Προοπτική μελέτη ελέγχου του προγνωστικού δείκτη "Larissa Heart Failure Risk Score" στην οξεία καρδιακή ανεπάρκεια
Abstract
dc:descriptionThere is limited information regarding outcome differences between acutely decompensated chronic heart failure (ADCHF) vs. De-novo HF as well the performance of the Larissa Heart Failure Risk Score (LHFRS) to predict outcomes during the early post hospital discharge (90 days) period, the so-called “vulnerable” phase by the HF type.We conducted a prospective study of consecutive patients admitted at the Cardiology clinic of a tertiary hospital (June 2019-August 2020). Inclusion criteria were as follows: (i) symptoms and/or signs of HF, (ii) NT-proBNP > 125 ng/L, and (iii) New York Heart Association (NYHA) functional class ≥ II. The exclusion criteria were as follows: (i) congenital heart disease, (ii) pericardial disease, (iii) severe anemia (hemoglobin <7 g/dL), (iv) estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2, and (v) severe valvular disease. LHFRS was measured upon admission. It consists of three variables (history of hypertension, history of coronary artery disease/myocardial infarction, and red blood cell distribution width). The absence of hypertension history, the presence of coronary artery disease/myocardial infarction history, and the admission of a red blood cell distribution width value ≥ 15% are assigned 2, 1, and 1 points, respectively. Patients with LHFRS = 0 have the best, whereas those with LHFRS = 4 have the worst prognosis. The primary and secondary outcomes were rehospitalization for HF within 90 days after hospital discharge (“vulnerable period”) and all-cause mortality during the same time period. Continuous data are expressed as median (interquartile range), whereas categorical variables as percentages. The Mann-Whitney U test and Fisher's exact test were used for the comparison of continuous and categorical variables, respectively. The association between LHFRS and outcomes was evaluated using logistic regression. When statistically significant odds ratios (ORs) were obtained, the LHFRS performance to classify patients according to event was evaluated with receiver operating characteristic (ROC) curves. SPSS (IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp) was used for data analysis. All statistical tests were two-sided, and a P-value < 0.05 was considered significant. The rehospitalization rate was significantly higher in ADCHF than in De-Novo HF [N = 25, (16.3%) vs. N = 4, (3.9%), P = 0.002]. All-cause mortality was similar in two HF types [N = 18, (11.8%) vs. N = 8 (7.8%), P = 0.299]. The LHFRS was associated with rehospitalizations in ADCHF [Odds Ratio (OR) 1.821, 95% Confidence Intervals (CI) (1.209-2.741), P = 0.004] but not in De-novo HF [OR 1.918, 95% CI (0.784-4.692), P = 0.154). The LHFRS was not associated with mortality both in ADCHF [OR 1.063, 95%CI (0.688-1.643), P = 0.783] and in De-novo HF [OR 0.632, 95% CI (0.273-1.462), P = 0.284]. Τhe LHFRS performance to classify patients in the ADCHF group according to the presence or absence of rehospitalization was acceptable (AUC = 0.69). Based on the analysis of the coordinates of the ROC curve, a LHFRS ≥1.5 detects rehospitalization of ADCHF patients with a sensitivity of 0.89 and a specificity of 0.45.Although the left ventricular ejection fraction (LVEF) was associated with the rehospitalization rate during the vulnerable period (OR = 0.963; 95% CI = 0.933-0.995), the LVEF-based patient classification was poor (area under the ROC curve = 0.325). Ischemic cardiomyopathy was not associated with the rehospitalization rate during the vulnerable period (OR = 0.623; CI = 0.246-1.578).The LHFRS may contribute to the identification of ADCHF but not De-Novo HF patients at high risk for HF rehospitalization early (90 days) after hospital discharge. LHFRS did not predict mortality in both HF types. The findings of the present study provide further evidence supporting fundamental differences regarding pathophysiology and outcomes in the two major types of acute HF (De-Novo vs. ADCHF). Indeed, patients with ADCHF exhibited significantly more rehospitalizations compared to those with De-Novo HF. Furthermore, the LHFRS, an established prognostic score in chronic HF, proved useful in predicting rehospitalizations during the early discharge period in ADCHF patients, suggesting that ADCHF may be an integral part of chronic HF. Numerous systematic reviews have previously investigated the prediction of unplanned hospital readmissions that focused specifically on patients with HF but the conclusion is generally the same; discrimination is poor to adequate, and there is little consistency in the type of predictors included in the models. Multiple scoring systems including HOSPITAL Score, LACE index, and LACE + index have been proposed, analyzed, and validated to help predict patients at high risk of early (within 30 days from discharge) readmission in general. However, the above scores were ineffective in predicting the 30-day all-cause readmission risk of patients with heart failure with preserved ejection fraction (HFpEF). Huynh Q et al. had proposed a predictive model for 30-day readmission or death in HF (excluding De-Novo diagnosis of HF) combining both clinical and nonclinical factors, but there was attenuation in discriminatory power of the model when used to predict outcomes within 90 days of discharge, and it is not considered as an easily manageable model. On the other hand, the measurement of LHFRS concerns the whole spectrum of heart failure with an acceptable discriminatory predictive power within 90 days of discharge. A good medical history analysis and a full blood count are the only variables that must be utilized. It is a low cost score with wide availability and easily obtainable. The primary and important role of LHFRS is to improve decision-making in emergent care, where decisions must be made quickly and accurately. In modern world, there is a need for the implementation of early risk stratification strategies to classify HF patients promptly, administer the appropriate therapy, and improve outcome. The LHFRS may be used to identify ADCHF patients at high risk for HF rehospitalization during the “vulnerable” phase. Whether the LHFRS can be utilized as a predictive tool in patients with advanced HF, a population with frequent rehospitalizations, needs to be elucidated in future studies.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimos, Apostolos
- Δήμος, Απόστολος
Subjects
dc:subject × 16- Καρδιακή ανεπάρκεια
- Επανανοσηλείες
- Ευάλωτη περίοδο
- Αιματολογικές παράμετροι
- Λάρισα
- Heart failure
- Rehospitalization
- Vulnerable phase
- Parameters
- Larissa Heart Failure Risk Score
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57074